Literature DB >> 1889417

Competitive inhibition of liver glucokinase by its regulatory protein.

A Vandercammen1, E Van Schaftingen.   

Abstract

The regulatory protein of rat liver glucokinase (hexokinase IV or D) behaved as a fully competitive inhibitor of this enzyme when glucose was the variable substrate, i.e. it increased the half-saturating concentration of glucose as a linear function of its concentration without affecting V (velocity at infinite concentration of substrate). The inhibition by the regulatory protein and that by palmitoyl-CoA were synergistic with that by N-acetyl-glucosamine, indicating that the two former inhibitors bind to a site distinct from the catalytic site. In contrast, the effects of the regulatory protein and palmitoyl-CoA were competitive with each other, indicating that these two inhibitors bind to the same site. The regulatory protein exerted a non-competitive inhibition with respect to Mg-ATP at concentrations of this nucleotide less than 0.5 mM. At higher concentrations, the latter antagonized the inhibition by the regulatory protein partly by decreasing the apparent affinity for fructose 6-phosphate. The following anions inhibited glucokinase non-competitively with respect to glucose: Pi, sulfate, I-, Br-, No3-, Cl-, F- and acetate. Pi and sulfate, at concentrations in the millimolar range, decreased the inhibition by the regulatory protein by competing with fructose 6-phosphate. Monovalent anions also antagonized the inhibition by the regulatory protein with the following order of potency: I- greater than Br- greater than NO3- greater than Cl- greater than F- greater than acetate and their effect was non-competitive with respect to fructose 6-phosphate. Glucokinase from Buffo marinus and pig liver were, like the rat liver enzyme, inhibited by the regulatory protein, as well as by palmitoyl-CoA at micromolar concentrations. In contrast, neither compound inhibited hexokinases from rat brain, beef heart or yeast, or the low-Km specific glucokinase from Bacillus stearothermophilus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889417     DOI: 10.1111/j.1432-1033.1991.tb16217.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  26 in total

1.  Multiplex inhibitor screening and kinetic constant determinations for yeast hexokinase using mass spectrometry based assays.

Authors:  Hong Gao; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2003-03       Impact factor: 3.109

2.  Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein.

Authors:  M Veiga-da-Cunha; L Z Xu; Y H Lee; D Marotta; S J Pilkis; E Van Schaftingen
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

3.  The regulatory protein of glucokinase binds to the hepatocyte matrix, but, unlike glucokinase, does not translocate during substrate stimulation.

Authors:  L Agius; M Peak; E Van Schaftingen
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

Review 4.  Glucokinase and candidate genes for type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P J Randle
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

Review 5.  Glycolysis revisited.

Authors:  E Van Schaftingen
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

6.  Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites.

Authors:  L Agius; M Stubbs
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

7.  Glial glucokinase expression in adult and post-natal development of the hypothalamic region.

Authors:  Carola Millán; Fernando Martínez; Christian Cortés-Campos; Isabel Lizama; Maria Jose Yañez; Paula Llanos; Karin Reinicke; Federico Rodríguez; Bruno Peruzzo; Francisco Nualart; Maria Angeles García
Journal:  ASN Neuro       Date:  2010-05-25       Impact factor: 4.146

Review 8.  The Randle cycle revisited: a new head for an old hat.

Authors:  Louis Hue; Heinrich Taegtmeyer
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

Review 9.  Assessing the potential of glucokinase activators in diabetes therapy.

Authors:  Franz M Matschinsky
Journal:  Nat Rev Drug Discov       Date:  2009-04-17       Impact factor: 84.694

10.  Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.

Authors:  Jung Min Choi; Moon-Hyeong Seo; Hyun-Ho Kyeong; Eunkyung Kim; Hak-Sung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.